{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:55:33Z","timestamp":1759334133200,"version":"build-2065373602"},"reference-count":256,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"grant of the state program of the \u00abSirius\u00bb Federal Territory \u00abScientific and technological development of the \u00abSirius\u00bb Federal Territory\u00bb","award":["18-03"],"award-info":[{"award-number":["18-03"]}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["IJMS"],"abstract":"<jats:p>The high prevalence and diversity of liver diseases present a significant problem for modern healthcare. Despite FDA approval of gene therapy drugs to treat hemophilia A and B, available treatment methods for other hereditary liver diseases are mainly limited to the frequently ineffective traditional therapies and surgical intervention. In recent years, significant progress has been made in the treatment of hepatitis C, but hepatitis B is still considered an incurable disease. In this regard, the treatment of hereditary and viral liver diseases using gene or cell therapy remains relevant. This review is focused on the current state of the induced pluripotent stem cells (iPSCs) field in the context of modeling and treatment of hereditary, viral, and some other liver diseases, both ex vivo and in vivo. Here we present a detailed discussion of the possible ways of modeling liver diseases ex vivo using iPSCs (reprogramming of patient somatic cells and genetic engineering (GE) of healthy iPSCs), summarize gene editing (GE) and non-GE approaches for the treatment of liver diseases, and demonstrate that iPSCs and their derivatives are widely used to treat liver diseases in vivo. Taken together, we are presenting a comprehensive analysis of 2D and 3D iPSC-based products in the context of liver diseases, discussing the advantages and disadvantages of this platform, including the comparison with other types of stem cells and animal models. This analysis may help understand not only the potential but also the limitations associated with the use of iPSCs in the context of various types of liver diseases.<\/jats:p>","DOI":"10.3390\/ijms26199432","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T14:50:38Z","timestamp":1758898238000},"page":"9432","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of Induced Pluripotent Stem Cells (iPSCs) in Hereditary and Viral Diseases of the Liver: Modeling and Treatment"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4338-8693","authenticated-orcid":false,"given":"Vladimir","family":"Andriianov","sequence":"first","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Malyutina","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9368-2287","authenticated-orcid":false,"given":"Egor","family":"Panferov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6391-5182","authenticated-orcid":false,"given":"Alexander","family":"Karabelsky","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9573-4183","authenticated-orcid":false,"given":"Roman","family":"Ivanov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1137-373X","authenticated-orcid":false,"given":"Ekaterina","family":"Minskaia","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-0804","authenticated-orcid":false,"given":"Vasiliy","family":"Reshetnikov","sequence":"additional","affiliation":[{"name":"Translational Medicine Research Center, Sirius University of Science and Technology, 354340 Sochi, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"ref_1","unstructured":"(2025, August 06). Hepatitis. Available online: https:\/\/www.who.int\/health-topics\/hepatitis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global Burden of Liver Disease: 2023 Update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J. Hepatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2018). EASL Recommendations on Treatment of Hepatitis C 2018. J. Hepatol., 69, 461\u2013511.","DOI":"10.1016\/j.jhep.2018.03.026"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2012.02.019","article-title":"Epidermal Growth Factor Receptor and HER-3 Restrict Cell Response to Sorafenib in Hepatocellular Carcinoma Cells","volume":"57","author":"Chettouh","year":"2012","journal-title":"J. Hepatol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature10761","article-title":"The Promise of Induced Pluripotent Stem Cells in Research and Therapy","volume":"481","author":"Robinton","year":"2012","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Kato, Y., Inaba, T., Shinke, K., Hiramatsu, N., Horie, T., Sakamoto, T., Hata, Y., Sugihara, E., Takimoto, T., and Nagai, N. (2025). Comprehensive Search for Genes Involved in Thalidomide Teratogenicity Using Early Differentiation Models of Human Induced Pluripotent Stem Cells: Potential Applications in Reproductive and Developmental Toxicity Testing. Cells, 14.","DOI":"10.3390\/cells14030215"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Dawoody Nejad, L., and Pioro, E.P. (2025). Modeling ALS with Patient-Derived iPSCs: Recent Advances and Future Potentials. Brain Sci., 15.","DOI":"10.3390\/brainsci15020134"},{"key":"ref_8","first-page":"43","article-title":"Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs)","volume":"10","author":"Singh","year":"2015","journal-title":"J. Stem Cells"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Flahou, C., Morishima, T., Takizawa, H., and Sugimoto, N. (2021). Fit-For-All iPSC-Derived Cell Therapies and Their Evaluation in Humanized Mice with NK Cell Immunity. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.662360"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Mah, N., Kurtz, A., Fuhr, A., Seltmann, S., Chen, Y., Bultjer, N., Dewender, J., Lual, A., Steeg, R., and Mueller, S.C. (2023). The Management of Data for the Banking, Qualification, and Distribution of Induced Pluripotent Stem Cells: Lessons Learned from the European Bank for Induced Pluripotent Stem Cells. Cells, 12.","DOI":"10.3390\/cells12232756"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Huang, C.-Y., Liu, C.-L., Ting, C.-Y., Chiu, Y.-T., Cheng, Y.-C., Nicholson, M.W., and Hsieh, P.C.H. (2019). Human iPSC Banking: Barriers and Opportunities. J. Biomed. Sci., 26.","DOI":"10.1186\/s12929-019-0578-x"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1016\/j.stemcr.2023.03.005","article-title":"History and Current Status of Clinical Studies Using Human Pluripotent Stem Cells","volume":"18","author":"Kobold","year":"2023","journal-title":"Stem Cell Rep."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Hui, K.K., and Yamanaka, S. (2024). iPS Cell Therapy 2.0: Preparing for next-Generation Regenerative Medicine. Bioessays, 46.","DOI":"10.1002\/bies.202400072"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1089\/scd.2020.0199","article-title":"Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-Like Cells as a Model to Study Autosomal Recessive Hypercholesterolemia","volume":"30","author":"Nikasa","year":"2021","journal-title":"Stem Cells Dev."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9253","DOI":"10.1073\/pnas.1323941111","article-title":"Targeted Inversion and Reversion of the Blood Coagulation Factor 8 Gene in Human iPS Cells Using TALENs","volume":"111","author":"Park","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/nbt.3275","article-title":"Cholangiocytes Derived from Human Induced Pluripotent Stem Cells for Disease Modeling and Drug Validation","volume":"33","author":"Sampaziotis","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Sakurai, F., Mitani, S., Yamamoto, T., Takayama, K., Tachibana, M., Watashi, K., Wakita, T., Iijima, S., Tanaka, Y., and Mizuguchi, H. (2017). Human Induced-Pluripotent Stem Cell-Derived Hepatocyte-like Cells as an in Vitro Model of Human Hepatitis B Virus Infection. Sci. Rep., 7.","DOI":"10.1038\/srep45698"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Sch\u00f6bel, A., R\u00f6sch, K., and Herker, E. (2018). Functional Innate Immunity Restricts Hepatitis C Virus Infection in Induced Pluripotent Stem Cell\u2013Derived Hepatocytes. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-22243-7"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Walsh, C., and Jin, S. (2024). Induced Pluripotent Stem Cells and CRISPR-Cas9 Innovations for Treating Alpha-1 Antitrypsin Deficiency and Glycogen Storage Diseases. Cells, 13.","DOI":"10.3390\/cells13121052"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"e0105","DOI":"10.1097\/HC9.0000000000000105","article-title":"Liver Organoids: Established Tools for Disease Modeling and Drug Development","volume":"7","author":"Sun","year":"2023","journal-title":"Hepatol. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Ouchi, R., and Koike, H. (2023). Modeling Human Liver Organ Development and Diseases with Pluripotent Stem Cell-Derived Organoids. Front. Cell Dev. Biol., 11.","DOI":"10.3389\/fcell.2023.1133534"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Luo, Q., Wang, N., Que, H., Mai, E., Hu, Y., Tan, R., Gu, J., and Gong, P. (2023). Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms241411592"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41536-022-00252-5","article-title":"Modelling Urea Cycle Disorders Using iPSCs","volume":"7","author":"Duff","year":"2022","journal-title":"NPJ Regen. Med."},{"key":"ref_24","first-page":"258","article-title":"Patient-Derived Induced Pluripotent Stem Cells for Alpha-1 Antitrypsin Deficiency Disease Modeling and Therapeutic Discovery","volume":"5","author":"Kaserman","year":"2018","journal-title":"Chronic Obstr. Pulm. Dis."},{"key":"ref_25","first-page":"368","article-title":"Induced Pluripotent Stem Cells for the Treatment of Liver Diseases: Novel Concepts","volume":"211","author":"Yao","year":"2022","journal-title":"Cells Tissues Organs"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Zhang, L., Pu, K., Liu, X., Bae, S.D.W., Nguyen, R., Bai, S., Li, Y., and Qiao, L. (2021). The Application of Induced Pluripotent Stem Cells Against Liver Diseases: An Update and a Review. Front. Med., 8.","DOI":"10.3389\/fmed.2021.644594"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MOG.0000000000000726","article-title":"Synthetic Human Livers for Modeling Metabolic Diseases","volume":"37","author":"Tafaleng","year":"2021","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Blaszkiewicz, J., and Duncan, S.A. (2022). Advancements in Disease Modeling and Drug Discovery Using iPSC-Derived Hepatocyte-like Cells. Genes, 13.","DOI":"10.3390\/genes13040573"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jhep.2013.04.004","article-title":"Monogenic Diseases That Can Be Cured by Liver Transplantation","volume":"59","author":"Fagiuoli","year":"2013","journal-title":"J. Hepatol."},{"key":"ref_30","unstructured":"Salen, P., and Babiker, H.M. (2025). Hemophilia A. StatPearls, StatPearls Publishing."},{"key":"ref_31","unstructured":"Alshaikhli, A., Killeen, R.B., and Rokkam, V.R. (2025). Hemophilia B. StatPearls, StatPearls Publishing."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ymgme.2013.07.008","article-title":"The Incidence of Urea Cycle Disorders","volume":"110","author":"Summar","year":"2013","journal-title":"Mol. Genet. Metab."},{"key":"ref_33","unstructured":"Ibrahim, M.A., Asuka, E., and Jialal, I. (2025). Hypercholesterolemia. StatPearls, StatPearls Publishing."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"i4","DOI":"10.1093\/ckj\/sfab217","article-title":"Primary Hyperoxaluria Type 1: Pathophysiology and Genetics","volume":"15","author":"Fargue","year":"2022","journal-title":"Clin. Kidney J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1080\/07853890701842988","article-title":"Senile Systemic Amyloidosis Affects 25% of the Very Aged and Associates with Genetic Variation in Alpha2-Macroglobulin and Tau: A Population-Based Autopsy Study","volume":"40","author":"Tanskanen","year":"2008","journal-title":"Ann. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/mus.26034","article-title":"Estimating the Global Prevalence of Transthyretin Familial Amyloid Polyneuropathy","volume":"57","author":"Schmidt","year":"2018","journal-title":"Muscle Nerve"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.omtm.2018.12.011","article-title":"Preclinical Development of an AAV8-hUGT1A1 Vector for the Treatment of Crigler-Najjar Syndrome","volume":"12","author":"Collaud","year":"2018","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_38","unstructured":"Nana, M., Anastasopoulou, C., Parikh, N.S., and Ahlawat, R. (2025). Glycogen Storage Disease Type I. StatPearls, StatPearls Publishing."},{"key":"ref_39","unstructured":"Meseeha, M., Sankari, A., and Attia, M. (2025). Alpha-1 Antitrypsin Deficiency. StatPearls, StatPearls Publishing."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/ejhg.2013.140","article-title":"Clinical Utility Gene Card for: Alagille Syndrome (ALGS)","volume":"22","author":"Leonard","year":"2014","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_41","unstructured":"A Siddiqi, I., and Tadi, P. (2025). Progressive Familial Intrahepatic Cholestasis. StatPearls, StatPearls Publishing."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/gim.2011.1","article-title":"Argininosuccinate Lyase Deficiency","volume":"14","author":"Erez","year":"2012","journal-title":"Genet. Med."},{"key":"ref_43","unstructured":"Immergluck, J., Grant, L.M., and Anilkumar, A.C. (2025). Wilson Disease. StatPearls, StatPearls Publishing."},{"key":"ref_44","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Tyrosinemia Type I. GeneReviews\u00ae, University of Washington."},{"key":"ref_45","unstructured":"Mitchell, G.A., Grompe, M., Lambert, M., and Tanguay, R.M. (2019). Hypertyrosinemia. The Online Metabolic and Molecular Bases of Inherited Disease, McGraw Hill Medical. Available online: https:\/\/ommbid.mhmedical.com\/content.aspx?bookid=2709&sectionid=225082825."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbabio.2004.09.005","article-title":"The Epidemiology of Mitochondrial Disorders\u2013Past, Present and Future","volume":"1659","author":"Schaefer","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_47","unstructured":"Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., and Amemiya, A. (1993). Niemann-Pick Disease Type C. GeneReviews\u00ae, University of Washington."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","article-title":"Wolman\u2019s Disease and Cholesteryl Ester Storage Disorder: The Phenotypic Spectrum of Lysosomal Acid Lipase Deficiency","volume":"2","author":"Pericleous","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Colburn, R., and Lapidus, D. (2023). An Analysis of Pompe Newborn Screening Data: A New Prevalence at Birth, Insight and Discussion. Front. Pediatr., 11.","DOI":"10.3389\/fped.2023.1221140"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Scotet, V., L\u2019Hostis, C., and F\u00e9rec, C. (2020). The Changing Epidemiology of Cystic Fibrosis: Incidence, Survival and Impact of the CFTR Gene Discovery. Genes, 11.","DOI":"10.3390\/genes11060589"},{"key":"ref_51","unstructured":"Junaid, S.Z.S., and Patel, K. (2025). Abetalipoproteinemia. StatPearls, StatPearls Publishing."},{"key":"ref_52","unstructured":"(2025, August 07). Hepatitis B. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-b."},{"key":"ref_53","unstructured":"(2025, August 07). Hepatitis C. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-c."},{"key":"ref_54","unstructured":"(2025, August 07). Hepatitis E. Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/hepatitis-e."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MPG.0b013e318282a913","article-title":"International Incidence and Outcomes of Biliary Atresia","volume":"56","author":"Fortinsky","year":"2013","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1750-1172-4-2","article-title":"Tetralogy of Fallot","volume":"4","author":"Bailliard","year":"2009","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_57","unstructured":"Kothadia, J.P., Kreitman, K., and Shah, J.M. (2025). Polycystic Liver Disease. StatPearls, StatPearls Publishing."},{"key":"ref_58","first-page":"1","article-title":"Human Disease Models in Drug Development","volume":"1","author":"Loewa","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jcmgh.2022.11.008","article-title":"In Vitro Models for the Study of Liver Biology and Diseases: Advances and Limitations","volume":"15","author":"Kaur","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15283\/ijsc24118","article-title":"Advanced Animal Replacement Testing Strategies Using Stem Cell and Organoids","volume":"18","author":"Lee","year":"2025","journal-title":"Int. J. Stem Cells"},{"key":"ref_61","first-page":"S627","article-title":"The Effect of Oleic and Palmitic Acid on Induction of Steatosis and Cytotoxicity on Rat Hepatocytes in Primary Culture","volume":"64","author":"Mezera","year":"2015","journal-title":"Physiol. Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3892\/etm.2016.3069","article-title":"Low Simvastatin Concentrations Reduce Oleic Acid-Induced Steatosis in HepG2 Cells: An in Vitro Model of Non-Alcoholic Fatty Liver Disease","volume":"11","author":"Alkhatatbeh","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Wu, Y., Hu, Z., Li, Z., Pang, J., Feng, M., Hu, X., Wang, X., Lin-Peng, S., Liu, B., and Chen, F. (2016). In Situ Genetic Correction of F8 Intron 22 Inversion in Hemophilia A Patient-Specific iPSCs. Sci. Rep., 6.","DOI":"10.1038\/srep18865"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1039\/C2TX20051A","article-title":"In Vitro Models for Liver Toxicity Testing","volume":"2","author":"Soldatow","year":"2013","journal-title":"Toxicol. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00204-020-02937-6","article-title":"Comparing in Vitro Human Liver Models to in Vivo Human Liver Using RNA-Seq","volume":"95","author":"Gupta","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0887-2333(02)00118-2","article-title":"Time Course of Cytochromes P450 Decline during Rat Hepatocyte Isolation and Culture: Effect of l-NAME","volume":"17","author":"Binda","year":"2003","journal-title":"Toxicol. Vitr."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Kaur, I., Vasudevan, A., Rawal, P., Tripathi, D.M., Ramakrishna, S., Kaur, S., and Sarin, S.K. (2023). Primary Hepatocyte Isolation and Cultures: Technical Aspects, Challenges and Advancements. Bioengineering, 10.","DOI":"10.3390\/bioengineering10020131"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cotox.2020.08.003","article-title":"Primary Hepatocyte Cultures for Liver Disease Modeling","volume":"25","author":"Vinken","year":"2021","journal-title":"Curr. Opin. Toxicol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1002\/hep.28780","article-title":"Massive Rearrangements of Cellular MicroRNA Signatures Are Key Drivers of Hepatocyte Dedifferentiation","volume":"64","author":"Lauschke","year":"2016","journal-title":"Hepatology"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00204-012-0983-3","article-title":"Primary Hepatocyte Cultures for Pharmaco-Toxicological Studies: At the Busy Crossroad of Various Anti-Dedifferentiation Strategies","volume":"87","author":"Fraczek","year":"2013","journal-title":"Arch. Toxicol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-4939-2074-7_5","article-title":"Culture and Functional Characterization of Human Hepatoma HepG2 Cells","volume":"1250","author":"Donato","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"Arzumanian, V.A., Kiseleva, O.I., and Poverennaya, E.V. (2021). The Curious Case of the HepG2 Cell Line: 40 Years of Expertise. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms222313135"},{"key":"ref_73","first-page":"51","article-title":"Culturing of HepG2 Cells with Human Serum Improve Their Functionality and Suitability in Studies of Lipid Metabolism","volume":"1861","author":"Pramfalk","year":"2016","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Cell Biol. Lipids"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"\u0160tampar, M., Breznik, B., Filipi\u010d, M., and \u017degura, B. (2020). Characterization of In Vitro 3D Cell Model Developed from Human Hepatocellular Carcinoma (HepG2) Cell Line. Cells, 9.","DOI":"10.3390\/cells9122557"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.tiv.2007.05.014","article-title":"Cytochrome P450 Enzyme Levels in HepG2 Cells and Cryopreserved Primary Human Hepatocytes and Their Induction in HepG2 Cells","volume":"21","author":"Westerink","year":"2007","journal-title":"Toxicol. Vitr."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.biotechadv.2014.01.003","article-title":"Pluripotent Stem Cell-Derived Hepatocyte-like Cells","volume":"32","author":"Schwartz","year":"2014","journal-title":"Biotechnol. Adv."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00441-024-03868-9","article-title":"Comparative Transcriptomic and Phenotypic Analysis of Induced Pluripotent Stem Cell Hepatocyte-like Cells and Primary Human Hepatocytes","volume":"396","author":"Gandhi","year":"2024","journal-title":"Cell Tissue Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s40139-016-0113-7","article-title":"Pluripotent Stem Cell-Derived Hepatocyte-like Cells: A Tool to Study Infectious Disease","volume":"4","author":"Schwartz","year":"2016","journal-title":"Curr. Pathobiol. Rep."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1038\/s41467-021-26410-9","article-title":"A Human Multi-Lineage Hepatic Organoid Model for Liver Fibrosis","volume":"12","author":"Guan","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/toxsci\/kfs230","article-title":"Metabolomics-on-a-Chip of Hepatotoxicity Induced by Anticancer Drug Flutamide and Its Active Metabolite Hydroxyflutamide Using HepG2\/C3a Microfluidic Biochips","volume":"132","author":"Bunescu","year":"2013","journal-title":"Toxicol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.tiv.2016.05.012","article-title":"Human Precision-Cut Liver Slices as a Model to Test Antifibrotic Drugs in the Early Onset of Liver Fibrosis","volume":"35","author":"Westra","year":"2016","journal-title":"Toxicol. Vitr."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"535","DOI":"10.4252\/wjsc.v11.i8.535","article-title":"Derivation and Applications of Human Hepatocyte-like Cells","volume":"11","author":"Li","year":"2019","journal-title":"World J. Stem Cells"},{"key":"ref_83","doi-asserted-by":"crossref","unstructured":"Qiu, S., Li, Y., Imakura, Y., Mima, S., Hashita, T., Iwao, T., and Matsunaga, T. (2021). An Efficient Method for the Differentiation of Human iPSC-Derived Endoderm toward Enterocytes and Hepatocytes. Cells, 10.","DOI":"10.3390\/cells10040812"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.bbadis.2018.08.038","article-title":"Liver Diseases in the Dish: iPSC and Organoids as a New Approach to Modeling Liver Diseases","volume":"1865","author":"Fiorotto","year":"2019","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"102763","DOI":"10.1016\/j.scr.2022.102763","article-title":"In Vitro Differentiation of Pluripotent Stem Cells into Hepatocyte like Cells-Basic Principles and Current Progress","volume":"61","author":"Graffmann","year":"2022","journal-title":"Stem Cell Res."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1242\/dev.150201","article-title":"The Hope and the Hype of Organoid Research","volume":"144","author":"Huch","year":"2017","journal-title":"Development"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2016.05.082","article-title":"Modeling Development and Disease with Organoids","volume":"165","author":"Clevers","year":"2016","journal-title":"Cell"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1093\/stmcls\/sxac090","article-title":"Self-Assembled Matrigel-Free iPSC-Derived Liver Organoids Demonstrate Wide-Ranging Highly Differentiated Liver Functions","volume":"41","author":"Weng","year":"2023","journal-title":"Stem Cells"},{"key":"ref_89","doi-asserted-by":"crossref","unstructured":"Olgasi, C., Cucci, A., and Follenzi, A. (2020). iPSC-Derived Liver Organoids: A Journey from Drug Screening, to Disease Modeling, Arriving to Regenerative Medicine. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21176215"},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Harrison, S.P., Baumgarten, S.F., Verma, R., Lunov, O., Dejneka, A., and Sullivan, G.J. (2021). Liver Organoids: Recent Developments, Limitations and Potential. Front. Med., 8.","DOI":"10.3389\/fmed.2021.574047"},{"key":"ref_91","doi-asserted-by":"crossref","unstructured":"Althali, N.J., and Hentges, K.E. (2022). Genetic Insights into Non-Syndromic Tetralogy of Fallot. Front. Physiol., 13.","DOI":"10.3389\/fphys.2022.1012665"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.bbrc.2017.03.037","article-title":"Modelling Urea-Cycle Disorder Citrullinemia Type 1 with Disease-Specific iPSCs","volume":"486","author":"Toyoda","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.stemcr.2019.08.007","article-title":"Robust, Long-Term Culture of Endoderm-Derived Hepatic Organoids for Disease Modeling","volume":"13","author":"Akbari","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e394","DOI":"10.1038\/mtna.2016.98","article-title":"Restoring Ureagenesis in Hepatocytes by CRISPR\/Cas9-Mediated Genomic Addition to Arginase-Deficient Induced Pluripotent Stem Cells","volume":"5","author":"Lee","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Sin, Y.Y., Price, P.R., Ballantyne, L.L., and Funk, C.D. (2017). Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency. Sci. Rep., 7.","DOI":"10.1038\/s41598-017-02927-2"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"101704","DOI":"10.1016\/j.scr.2020.101704","article-title":"Generation of an Induced Pluripotent Stem Cell Line (SDQLCHi009-A) from a Patient with 47,XXY and Ornithine Transcarbamylase Deficiency Carrying a Hemizygote Mutation in OTC","volume":"43","author":"Yang","year":"2020","journal-title":"Stem Cell Res."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"102220","DOI":"10.1016\/j.scr.2021.102220","article-title":"Generation of a Human Induced Pluripotent Stem Cell Line (SDQLCHi036-A) from a Patient with Ornithine Transcarbamylase Deficiency Carrying a Deletion Involving 3\u20139 Exons of OTC Gene","volume":"52","author":"Guan","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Zabulica, M., Jakobsson, T., Ravaioli, F., Vosough, M., Gramignoli, R., Ellis, E., Rooyackers, O., and Strom, S.C. (2021). Gene Editing Correction of a Urea Cycle Defect in Organoid Stem Cell Derived Hepatocyte-like Cells. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22031217"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/hep.32247","article-title":"Aquaporin 9 Induction in Human iPSC-derived Hepatocytes Facilitates Modeling of Ornithine Transcarbamylase Deficiency","volume":"76","author":"Laemmle","year":"2022","journal-title":"Hepatology"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0974-2069.132478","article-title":"Familial Hypercholesterolemia: A Review","volume":"7","author":"Varghese","year":"2014","journal-title":"Ann. Pediatr. Cardiol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1002\/hep.25871","article-title":"\u2018JD\u2019 iPS Cell\u2013Derived Hepatocytes Faithfully Recapitulate the Pathophysiology of Familial Hypercholesterolemia","volume":"56","author":"Cayo","year":"2012","journal-title":"Hepatology"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.stem.2017.01.011","article-title":"A Drug Screen Using Human iPSC-Derived Hepatocyte-like Cells Identifies Cardiac Glycosides as a Potential Treatment for Hypercholesterolemia","volume":"20","author":"Cayo","year":"2017","journal-title":"Cell Stem Cell"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep4.1110","article-title":"CRISPR Correction of a Homozygous Low-density Lipoprotein Receptor Mutation in Familial Hypercholesterolemia Induced Pluripotent Stem Cells","volume":"1","author":"Omer","year":"2017","journal-title":"Hepatol. Commun."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s12033-012-9635-3","article-title":"Disease-Corrected Hepatocyte-like Cells from Familial Hypercholesterolemia-Induced Pluripotent Stem Cells","volume":"54","author":"Fattahi","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"ref_105","unstructured":"Konkle, B.A., and Nakaya Fletcher, S. (1993). Hemophilia A., University of Washington."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1111\/jth.12958","article-title":"Hemophilia B: Molecular Pathogenesis and Mutation Analysis","volume":"13","author":"Goodeve","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.lfs.2014.05.004","article-title":"Modeling of Hemophilia A Using Patient-Specific Induced Pluripotent Stem Cells Derived from Urine Cells","volume":"108","author":"Jia","year":"2014","journal-title":"Life Sci."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/jth.13808","article-title":"Advanced Cell-Based Modeling of the Royal Disease: Characterization of the Mutated F9 mRNA","volume":"15","author":"Martorell","year":"2017","journal-title":"J. Thromb. Haemost."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"101948","DOI":"10.1016\/j.scr.2020.101948","article-title":"Generation of a Gene Edited Hemophilia A Patient-Derived iPSC Cell Line, YCMi001-B-1, by Targeted Insertion of Coagulation Factor FVIII Using CRISPR\/Cas9","volume":"48","author":"Sung","year":"2020","journal-title":"Stem Cell Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.stemcr.2019.04.016","article-title":"Universal Correction of Blood Coagulation Factor VIII in Patient-Derived Induced Pluripotent Stem Cells Using CRISPR\/Cas9","volume":"12","author":"Park","year":"2019","journal-title":"Stem Cell Rep."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/hep.32211","article-title":"In Vitro Recovery of FIX Clotting Activity as a Marker of Highly Functional Hepatocytes in a Hemophilia B iPSC Model","volume":"75","author":"Luce","year":"2022","journal-title":"Hepatology"},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Tang, Q., Hu, Z., Zhao, J., Zhou, T., Tang, S., Wang, P., Xiao, R., Chen, Y., Wu, L., and Zhou, M. (2023). CRISPR-Mediated In Situ Introduction or Integration of F9-Padua in Human iPSCs for Gene Therapy of Hemophilia B. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24109013"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s43856-023-00286-w","article-title":"PAM-Flexible Cas9-Mediated Base Editing of a Hemophilia B Mutation in Induced Pluripotent Stem Cells","volume":"3","author":"Hiramoto","year":"2023","journal-title":"Commun. Med."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s13287-025-04195-8","article-title":"Development of iPSC-Derived FIX-Secreting Hepatocyte Sheet as a Novel Treatment Tool for Hemophilia B Treatment","volume":"16","author":"Bayarsaikhan","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"jcs219824","DOI":"10.1242\/jcs.219824","article-title":"Hepatocyte-like Cells Reveal Novel Role of SERPINA1 in Transthyretin Amyloidosis","volume":"131","author":"Niemietz","year":"2018","journal-title":"J. Cell Sci."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Niemietz, C.J., Sauer, V., Stella, J., Fleischhauer, L., Chandhok, G., Guttmann, S., Avsar, Y., Guo, S., Ackermann, E.J., and Gollob, J. (2016). Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0161455"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1182\/blood-2011-03-340620","article-title":"Reprogramming of EBV-Immortalized B-Lymphocyte Cell Lines into Induced Pluripotent Stem Cells","volume":"118","author":"Choi","year":"2011","journal-title":"Blood"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/hep.27753","article-title":"Induced Pluripotent Stem Cells Model Personalized Variations in Liver Disease Due to A1-Antitrypsin Deficiency","volume":"62","author":"Tafaleng","year":"2015","journal-title":"Hepatology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.jhep.2018.05.028","article-title":"hiPSC Hepatocyte Model Demonstrates the Role of Unfolded Protein Response and Inflammatory Networks in A1-Antitrypsin Deficiency","volume":"69","author":"Segeritz","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1002\/hep.29035","article-title":"Activation of the C-Jun N-Terminal Kinase Pathway Aggravates Proteotoxicity of Hepatic Mutant Z Alpha1-Antitrypsin","volume":"65","author":"Pastore","year":"2017","journal-title":"Hepatology"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.stemcr.2015.02.021","article-title":"Emergence of a Stage-Dependent Human Liver Disease Signature with Directed Differentiation of Alpha-1 Antitrypsin-Deficient iPS Cells","volume":"4","author":"Wilson","year":"2015","journal-title":"Stem Cell Rep."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.stemcr.2020.06.006","article-title":"A Highly Phenotyped Open Access Repository of Alpha-1 Antitrypsin Deficiency Pluripotent Stem Cells","volume":"15","author":"Kaserman","year":"2020","journal-title":"Stem Cell Rep."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/mt.2014.226","article-title":"Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs","volume":"23","author":"Smith","year":"2015","journal-title":"Mol. Ther."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5966\/sctm.2013-0017","article-title":"Sustained Knockdown of a Disease-Causing Gene in Patient-Specific Induced Pluripotent Stem Cells Using Lentiviral Vector-Based Gene Therapy","volume":"2","author":"Eggenschwiler","year":"2013","journal-title":"Stem Cells Transl. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1002\/hep.26237","article-title":"Efficient drug screening and gene correction for treating liver disease using patient-specific stem cells","volume":"57","author":"Choi","year":"2013","journal-title":"Hepatology"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1016\/j.ymthe.2021.06.021","article-title":"Adenine Base Editing Reduces Misfolded Protein Accumulation and Toxicity in Alpha-1 Antitrypsin Deficient Patient iPSC-Hepatocytes","volume":"29","author":"Werder","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"102447","DOI":"10.1016\/j.scr.2021.102447","article-title":"Generation of an Induced Pluripotent Stem Cell Line (TRNDi031-A) from a Patient with Alagille Syndrome Type 1 Carrying a Heterozygous p. C312X (c. 936 T > A) Mutation in JAGGED-1","volume":"54","author":"Brooks","year":"2021","journal-title":"Stem Cell Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"e94954","DOI":"10.1172\/jci.insight.94954","article-title":"Human Hepatic Organoids for the Analysis of Human Genetic Diseases","volume":"2","author":"Guan","year":"2017","journal-title":"JCI Insight"},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Imagawa, K., Takayama, K., Isoyama, S., Tanikawa, K., Shinkai, M., Harada, K., Tachibana, M., Sakurai, F., Noguchi, E., and Hirata, K. (2017). Generation of a Bile Salt Export Pump Deficiency Model Using Patient-Specific Induced Pluripotent Stem Cell-Derived Hepatocyte-like Cells. Sci. Rep., 7.","DOI":"10.1038\/srep41806"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.stemcr.2020.12.008","article-title":"Modeling Human Bile Acid Transport and Synthesis in Stem Cell-Derived Hepatocytes with a Patient-Specific Mutation","volume":"16","author":"Hayashi","year":"2021","journal-title":"Stem Cell Rep."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s13238-012-2064-z","article-title":"Establishment of Hepatic and Neural Differentiation Platforms of Wilson\u2019s Disease Specific Induced Pluripotent Stem Cells","volume":"3","author":"Yi","year":"2012","journal-title":"Protein Cell"},{"key":"ref_132","doi-asserted-by":"crossref","unstructured":"Parisi, S., Polishchuk, E.V., Allocca, S., Ciano, M., Musto, A., Gallo, M., Perone, L., Ranucci, G., Iorio, R., and Polishchuk, R.S. (2018). Characterization of the Most Frequent ATP7B Mutation Causing Wilson Disease in Hepatocytes from Patient Induced Pluripotent Stem Cells. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-24717-0"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jhep.2019.03.031","article-title":"Pluripotent Stem Cell-Derived Bile Canaliculi-Forming Hepatocytes to Study Genetic Liver Diseases Involving Hepatocyte Polarity","volume":"71","author":"Overeem","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1039\/C7MT00189D","article-title":"Downregulation of Hepatic Multi-Drug Resistance Protein 1 (MDR1) after Copper Exposure","volume":"9","author":"Groba","year":"2017","journal-title":"Metallomics"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"3176","DOI":"10.1093\/hmg\/ddr223","article-title":"Rescue of ATP7B Function in Hepatocyte-like Cells from Wilson\u2019s Disease Induced Pluripotent Stem Cells Using Gene Therapy or the Chaperone Drug Curcumin","volume":"20","author":"Zhang","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1172\/JCI85226","article-title":"Methanobactin Reverses Acute Liver Failure in a Rat Model of Wilson Disease","volume":"126","author":"Lichtmannegger","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/gtc.12101","article-title":"Establishment and Directed Differentiation of Induced Pluripotent Stem Cells from Glycogen Storage Disease Type Ib Patient","volume":"18","author":"Satoh","year":"2013","journal-title":"Genes Cells"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1002\/stem.1917","article-title":"HPGCD Outperforms HPBCD as a Potential Treatment for Niemann-Pick Disease Type C during Disease Modeling with iPS Cells","volume":"33","author":"Soga","year":"2015","journal-title":"Stem Cells"},{"key":"ref_139","doi-asserted-by":"crossref","unstructured":"V\u00f6lkner, C., Pantoom, S., Liedtke, M., Lukas, J., Hermann, A., and Frech, M.J. (2022). Assessment of FDA-Approved Drugs as a Therapeutic Approach for Niemann-Pick Disease Type C1 Using Patient-Specific iPSC-Based Model Systems. Cells, 11.","DOI":"10.3390\/cells11030319"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.stemcr.2014.03.014","article-title":"Genetic and Chemical Correction of Cholesterol Accumulation and Impaired Autophagy in Hepatic and Neural Cells Derived from Niemann-Pick Type C Patient-Specific iPS Cells","volume":"2","author":"Maetzel","year":"2014","journal-title":"Stem Cell Rep."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"2004680","DOI":"10.1002\/advs.202004680","article-title":"A Combined Model of Human iPSC-Derived Liver Organoids and Hepatocytes Reveals Ferroptosis in DGUOK Mutant mtDNA Depletion Syndrome","volume":"8","author":"Guo","year":"2021","journal-title":"Adv. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.celrep.2018.10.036","article-title":"A Screen Using iPSC-Derived Hepatocytes Reveals NAD+ as a Potential Treatment for mtDNA Depletion Syndrome","volume":"25","author":"Jing","year":"2018","journal-title":"Cell Rep."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/hep.27712","article-title":"Valproic Acid-Induced Hepatotoxicity in Alpers Syndrome Is Associated with Mitochondrial Permeability Transition Pore Opening-Dependent Apoptotic Sensitivity in an Induced Pluripotent Stem Cell Model","volume":"61","author":"Li","year":"2015","journal-title":"Hepatology"},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nbt.3294","article-title":"Directed Differentiation of Cholangiocytes from Human Pluripotent Stem Cells","volume":"33","author":"Ogawa","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/hep.29400","article-title":"Src Kinase Inhibition Reduces Inflammatory and Cytoskeletal Changes in \u0394F508 Human Cholangiocytes and Improves CFTR Correctors Efficacy","volume":"67","author":"Fiorotto","year":"2018","journal-title":"Hepatology"},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"101435","DOI":"10.1016\/j.scr.2019.101435","article-title":"A Human Induced Pluripotent Stem Cell Line (TRNDi007-B) from an Infantile Onset Pompe Patient Carrying p.R854X Mutation in the GAA Gene","volume":"37","author":"Cheng","year":"2019","journal-title":"Stem Cell Res."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","article-title":"Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids","volume":"30","author":"Ouchi","year":"2019","journal-title":"Cell Metab."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.celrep.2017.04.064","article-title":"Lack of MTTP Protein in Pluripotent Stem Cell-Derived Hepatocytes\/Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress","volume":"19","author":"Liu","year":"2017","journal-title":"Cell Rep."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"101467","DOI":"10.1016\/j.scr.2019.101467","article-title":"Generation of Induced Pluripotent Stem Cells-Derived Hepatocyte-like Cells for Ex Vivo Gene Therapy of Primary Hyperoxaluria Type 1","volume":"38","author":"Blouin","year":"2019","journal-title":"Stem Cell Res."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1073\/pnas.1412631111","article-title":"Modeling Host Interactions with Hepatitis B Virus Using Primary and Induced Pluripotent Stem Cell-Derived Hepatocellular Systems","volume":"111","author":"Shlomai","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_151","doi-asserted-by":"crossref","unstructured":"Chen, S.-W., Himeno, M., Koui, Y., Sugiyama, M., Nishitsuji, H., Mizokami, M., Shimotohno, K., Miyajima, A., and Kido, T. (2020). Modulation of Hepatitis B Virus Infection by Epidermal Growth Factor Secreted from Liver Sinusoidal Endothelial Cells. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-71453-5"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.jhep.2016.10.009","article-title":"Human Stem Cell-Derived Hepatocytes as a Model for Hepatitis B Virus Infection, Spreading and Virus-Host Interactions","volume":"66","author":"Xia","year":"2017","journal-title":"J. Hepatol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ebiom.2018.08.014","article-title":"Recapitulation of Hepatitis B Virus\u2013Host Interactions in Liver Organoids from Human Induced Pluripotent Stem Cells","volume":"35","author":"Nie","year":"2018","journal-title":"eBioMedicine"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Kaneko, S., Kakinuma, S., Asahina, Y., Kamiya, A., Miyoshi, M., Tsunoda, T., Nitta, S., Asano, Y., Nagata, H., and Otani, S. (2016). Human Induced Pluripotent Stem Cell-Derived Hepatic Cell Lines as a New Model for Host Interaction with Hepatitis B Virus. Sci. Rep., 6.","DOI":"10.1038\/srep29358"},{"key":"ref_155","doi-asserted-by":"crossref","unstructured":"Wu, X., Robotham, J.M., Lee, E., Dalton, S., Kneteman, N.M., Gilbert, D.M., and Tang, H. (2012). Productive Hepatitis C Virus Infection of Stem Cell-Derived Hepatocytes Reveals a Critical Transition to Viral Permissiveness during Differentiation. PLoS Pathog., 8.","DOI":"10.1371\/journal.ppat.1002617"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12985-016-0519-1","article-title":"A Robust Model of Natural Hepatitis C Infection Using Hepatocyte-like Cells Derived from Human Induced Pluripotent Stem Cells as a Long-Term Host","volume":"13","author":"Wongkajornsilp","year":"2016","journal-title":"Virol. J."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.virusres.2017.09.004","article-title":"Hepatitis C Virus-Induced Innate Immune Responses in Human iPS Cell-Derived Hepatocyte-like Cells","volume":"242","author":"Sakurai","year":"2017","journal-title":"Virus Res."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1073\/pnas.1121400109","article-title":"Modeling Hepatitis C Virus Infection Using Human Induced Pluripotent Stem Cells","volume":"109","author":"Schwartz","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbrc.2011.11.007","article-title":"Use of Human Hepatocyte-like Cells Derived from Induced Pluripotent Stem Cells as a Model for Hepatocytes in Hepatitis C Virus Infection","volume":"416","author":"Yoshida","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jhep.2015.11.013","article-title":"Stem Cell-Derived Hepatocytes: A Novel Model for Hepatitis E Virus Replication","volume":"64","author":"Helsen","year":"2016","journal-title":"J. Hepatol."},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1053\/j.gastro.2015.09.011","article-title":"Sofosbuvir Inhibits Hepatitis E Virus Replication In Vitro and Results in an Additive Effect When Combined with Ribavirin","volume":"150","author":"Debing","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/j.gastro.2017.10.041","article-title":"Pan-Genotype Hepatitis E Virus Replication in Stem Cell-Derived Hepatocellular Systems","volume":"154","author":"Wu","year":"2018","journal-title":"Gastroenterology"},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A Human Pluripotent Stem Cell-Based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/MPG.0000000000002187","article-title":"Biliary Atresia Relevant Human Induced Pluripotent Stem Cells Recapitulate Key Disease Features in a Dish","volume":"68","author":"Tian","year":"2019","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1053\/j.gastro.2015.08.034","article-title":"Zebrafish: An Important Tool for Liver Disease Research","volume":"149","author":"Goessling","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajpath.2016.09.013","article-title":"Chronic Phenotype Characterization of a Large-Animal Model of Hereditary Tyrosinemia Type 1","volume":"187","author":"Elgilani","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_167","doi-asserted-by":"crossref","unstructured":"Wang, H., Tan, T., Wang, J., Niu, Y., Yan, Y., Guo, X., Kang, Y., Duan, Y., Chang, S., and Liao, J. (2015). Rhesus Monkey Model of Liver Disease Reflecting Clinical Disease Progression and Hepatic Gene Expression Analysis. Sci. Rep., 5.","DOI":"10.1038\/srep15019"},{"key":"ref_168","first-page":"502","article-title":"Instant Cirrhosis. An Improved Method for Producing Cirrhosis of the Liver in Rats by Simultaneous Administration of Carbon Tetrachloride and Phenobarbitone","volume":"50","author":"McLean","year":"1969","journal-title":"Br. J. Exp. Pathol."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","article-title":"Experimental Models of Hepatocellular Carcinoma","volume":"48","author":"Newell","year":"2008","journal-title":"J. Hepatol."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"G1070","DOI":"10.1152\/ajpgi.00228.2004","article-title":"Oxidative DNA Damage and DNA Repair Enzyme Expression Are Inversely Related in Murine Models of Fatty Liver Disease","volume":"287","author":"Gao","year":"2004","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jhep.2018.03.011","article-title":"A Simple Diet-and Chemical-Induced Murine NASH Model with Rapid Progression of Steatohepatitis, Fibrosis and Liver Cancer","volume":"69","author":"Tsuchida","year":"2018","journal-title":"J. Hepatol."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"G323","DOI":"10.1152\/ajpgi.00394.2009","article-title":"Macrophage-Mediated Phagocytosis of Apoptotic Cholangiocytes Contributes to Reversal of Experimental Biliary Fibrosis","volume":"298","author":"Popov","year":"2010","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/978-1-4939-6506-9_9","article-title":"Gunn Rats as a Surrogate Model for Evaluation of Hepatocyte Transplantation-Based Therapies of Crigler-Najjar Syndrome Type 1","volume":"1506","author":"Polgar","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"ref_174","first-page":"59","article-title":"Transgenic Mice as a Chemotherapeutic Model for Hepatitis B Virus Infection","volume":"3","author":"Morrey","year":"1998","journal-title":"Antivir. Ther."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1053\/j.gastro.2004.07.019","article-title":"Hepatocyte-Specific Disruption of Bcl-xL Leads to Continuous Hepatocyte Apoptosis and Liver Fibrotic Responses","volume":"127","author":"Takehara","year":"2004","journal-title":"Gastroenterology"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1086\/338266","article-title":"The Hepatitis C Virus (HCV)-Trimera Mouse: A Model for Evaluation of Agents against HCV","volume":"185","author":"Ilan","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"111321","DOI":"10.1016\/j.celrep.2022.111321","article-title":"Human Hepatocyte PNPLA3-148M Exacerbates Rapid Non-Alcoholic Fatty Liver Disease Development in Chimeric Mice","volume":"40","author":"Kabbani","year":"2022","journal-title":"Cell Rep."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"G1321","DOI":"10.1152\/ajpgi.00455.2004","article-title":"Steatohepatitis Develops Rapidly in Transgenic Mice Overexpressing Abcb11 and Fed a Methionine-Choline-Deficient Diet","volume":"288","author":"Sundaram","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"ref_179","first-page":"5","article-title":"Animal Models in Translational Medicine: Validation and Prediction","volume":"2","author":"Denayer","year":"2014","journal-title":"New Horiz. Transl. Med."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.ajhg.2018.07.008","article-title":"Argininosuccinate Lyase Deficiency Causes an Endothelial-Dependent Form of Hypertension","volume":"103","author":"Kho","year":"2018","journal-title":"Am. J. Hum. Genet."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s13287-018-0839-8","article-title":"Targeted Genome Engineering in Human Induced Pluripotent Stem Cells from Patients with Hemophilia B Using the CRISPR-Cas9 System","volume":"9","author":"Lyu","year":"2018","journal-title":"Stem Cell Res. Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"82ra39","DOI":"10.1126\/scitranslmed.3002376","article-title":"In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins","volume":"3","author":"Liu","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3727\/096368915X689541","article-title":"Hepatocyte-Like Cells Derived from Mouse Induced Pluripotent Stem Cells Produce Functional Coagulation Factor IX in a Hemophilia B Mouse Model","volume":"25","author":"Wu","year":"2016","journal-title":"Cell Transplant."},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.celrep.2018.03.121","article-title":"Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX","volume":"23","author":"Ramaswamy","year":"2018","journal-title":"Cell Rep."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"881","DOI":"10.3324\/haematol.2014.123117","article-title":"Extrahepatic Sources of Factor VIII Potentially Contribute to the Coagulation Cascade Correcting the Bleeding Phenotype of Mice with Hemophilia A","volume":"100","author":"Zanolini","year":"2015","journal-title":"Haematologica"},{"key":"ref_186","doi-asserted-by":"crossref","unstructured":"Qiu, L., Xie, M., Zhou, M., Liu, X., Hu, Z., and Wu, L. (2021). Restoration of FVIII Function and Phenotypic Rescue in Hemophilia A Mice by Transplantation of MSCs Derived from F8-Modified iPSCs. Front. Cell Dev. Biol., 9.","DOI":"10.3389\/fcell.2021.630353"},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/s12276-024-01375-z","article-title":"Long-Term Correction of Hemophilia A via Integration of a Functionally Enhanced FVIII Gene into the AAVS1 Locus by Nickase in Patient-Derived iPSCs","volume":"57","author":"Kim","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.stem.2015.07.001","article-title":"Functional Correction of Large Factor VIII Gene Chromosomal Inversions in Hemophilia A Patient-Derived iPSCs Using CRISPR-Cas9","volume":"17","author":"Park","year":"2015","journal-title":"Cell Stem Cell"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1002\/sctm.19-0261","article-title":"Endothelial Cells Derived from Patients\u2019 Induced Pluripotent Stem Cells for Sustained Factor VIII Delivery and the Treatment of Hemophilia A","volume":"9","author":"Rose","year":"2020","journal-title":"Stem Cells Transl. Med."},{"key":"ref_190","doi-asserted-by":"crossref","unstructured":"Son, J.S., Park, C.-Y., Lee, G., Park, J.Y., Kim, H.J., Kim, G., Chi, K.Y., Woo, D.-H., Han, C., and Kim, S.K. (2022). Therapeutic Correction of Hemophilia A Using 2D Endothelial Cells and Multicellular 3D Organoids Derived from CRISPR\/Cas9-Engineered Patient iPSCs. Biomaterials, 283.","DOI":"10.1016\/j.biomaterials.2022.121429"},{"key":"ref_191","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.stemcr.2018.10.012","article-title":"Patient-Specific iPSC-Derived Endothelial Cells Provide Long-Term Phenotypic Correction of Hemophilia A","volume":"11","author":"Olgasi","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"S180","DOI":"10.1016\/S1525-0016(16)34804-3","article-title":"469. iPSC-Based Strategy To Correct the Bleeding Phenotype in Hemophilia A Targeting FVIII Expression to Endothelial Cells","volume":"21","author":"Talmon","year":"2013","journal-title":"Mol. Ther."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/0963689717751734","article-title":"Human iPS Cell-Based Liver-like Tissue Engineering at Extrahepatic Sites in Mice as a New Cell Therapy for Hemophilia B","volume":"27","author":"Okamoto","year":"2018","journal-title":"Cell Transplant."},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1172\/JCI75456","article-title":"Engrafted Human Stem Cell-Derived Hepatocytes Establish an Infectious HCV Murine Model","volume":"124","author":"Carpentier","year":"2014","journal-title":"J. Clin. Investig."},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.stemcr.2018.04.002","article-title":"Large-Scale Expansion of Human iPSC-Derived Skeletal Muscle Cells for Disease Modeling and Cell-Based Therapeutic Strategies","volume":"10","author":"Wan","year":"2018","journal-title":"Stem Cell Rep."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1089\/scd.2018.0010","article-title":"Transplanted Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells Support Liver Regeneration in Gunn Rats","volume":"27","author":"Spitzhorn","year":"2018","journal-title":"Stem Cells Dev."},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.omtn.2017.11.012","article-title":"Transplantation of Gene-Edited Hepatocyte-like Cells Modestly Improves Survival of Arginase-1-Deficient Mice","volume":"10","author":"Sin","year":"2017","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature10424","article-title":"Targeted Gene Correction of A1-Antitrypsin Deficiency in Induced Pluripotent Stem Cells","volume":"478","author":"Yusa","year":"2011","journal-title":"Nature"},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.biomaterials.2018.07.043","article-title":"Human iPS Derived Progenitors Bioengineered into Liver Organoids Using an Inverted Colloidal Crystal Poly (Ethylene Glycol) Scaffold","volume":"182","author":"Ng","year":"2018","journal-title":"Biomaterials"},{"key":"ref_200","doi-asserted-by":"crossref","unstructured":"Panferov, E., Dodina, M., Reshetnikov, V., Ryapolova, A., Ivanov, R., Karabelsky, A., and Minskaia, E. (2025). Induced Pluripotent (iPSC) and Mesenchymal (MSC) Stem Cells for In Vitro Disease Modeling and Regenerative Medicine. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26125617"},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1038\/s41467-020-15337-2","article-title":"Stem Cell-Derived Polarized Hepatocytes","volume":"11","author":"Wu","year":"2020","journal-title":"Nat. Commun."},{"key":"ref_202","doi-asserted-by":"crossref","unstructured":"Scesa, G., Adami, R., and Bottai, D. (2021). iPSC Preparation and Epigenetic Memory: Does the Tissue Origin Matter?. Cells, 10.","DOI":"10.3390\/cells10061470"},{"key":"ref_203","doi-asserted-by":"crossref","unstructured":"Lin, Y.-H., Lehle, J.D., and McCarrey, J.R. (2024). Source Cell-Type Epigenetic Memory Persists in Induced Pluripotent Cells but Is Lost in Subsequently Derived Germline Cells. Front. Cell Dev. Biol., 12.","DOI":"10.3389\/fcell.2024.1306530"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"E11111","DOI":"10.1073\/pnas.1708991114","article-title":"Molecular and Functional Resemblance of Differentiated Cells Derived from Isogenic Human iPSCs and SCNT-Derived ESCs","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/cbin.11725","article-title":"The Role of Mesenchymal Stem Cells in Liver Injury","volume":"46","author":"Sun","year":"2022","journal-title":"Cell. Biol. Int."},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1634\/stemcells.22-3-377","article-title":"Mesenchymal Stem Cells Can Be Differentiated into Endothelial Cells in Vitro","volume":"22","author":"Oswald","year":"2004","journal-title":"Stem Cells"},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"566","DOI":"10.21037\/atm.2020.02.164","article-title":"Induced Pluripotent Stem Cells for the Treatment of Liver Diseases: Challenges and Perspectives from a Clinical Viewpoint","volume":"8","author":"Pareja","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_208","doi-asserted-by":"crossref","unstructured":"Itakura, G., Kobayashi, Y., Nishimura, S., Iwai, H., Takano, M., Iwanami, A., Toyama, Y., Okano, H., and Nakamura, M. (2015). Controlling Immune Rejection Is a Fail-Safe System against Potential Tumorigenicity after Human iPSC-Derived Neural Stem Cell Transplantation. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0116413"},{"key":"ref_209","doi-asserted-by":"crossref","first-page":"15015","DOI":"10.1038\/celldisc.2015.15","article-title":"Immunogenicity and Functional Evaluation of iPSC-Derived Organs for Transplantation","volume":"1","author":"Wang","year":"2015","journal-title":"Cell Discov."},{"key":"ref_210","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of Induced Pluripotent Stem Cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"ref_211","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1038\/nm.3267","article-title":"Tumorigenicity as a Clinical Hurdle for Pluripotent Stem Cell Therapies","volume":"19","author":"Lee","year":"2013","journal-title":"Nat. Med."},{"key":"ref_212","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/jcb.21912","article-title":"Retroviral Vector Silencing during iPS Cell Induction: An Epigenetic Beacon That Signals Distinct Pluripotent States","volume":"105","author":"Hotta","year":"2008","journal-title":"J. Cell. Biochem."},{"key":"ref_213","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5662\/wjm.v5.i3.108","article-title":"Hepatocyte Selection Medium Eliminating Induced Pluripotent Stem Cells among Primary Human Hepatocytes","volume":"5","author":"Tomizawa","year":"2015","journal-title":"World J. Methodol."},{"key":"ref_214","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1016\/j.biomaterials.2011.05.009","article-title":"Reprogramming Induced Pluripotent Stem Cells in the Absence of C-Myc for Differentiation into Hepatocyte-like Cells","volume":"32","author":"Li","year":"2011","journal-title":"Biomaterials"},{"key":"ref_215","doi-asserted-by":"crossref","unstructured":"Liu, X., Li, W., Fu, X., and Xu, Y. (2017). The Immunogenicity and Immune Tolerance of Pluripotent Stem Cell Derivatives. Front. Immunol., 8.","DOI":"10.3389\/fimmu.2017.00645"},{"key":"ref_216","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","article-title":"Hypoimmunogenic Derivatives of Induced Pluripotent Stem Cells Evade Immune Rejection in Fully Immunocompetent Allogeneic Recipients","volume":"37","author":"Deuse","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_217","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nprot.2012.153","article-title":"Production of Hepatocyte-like Cells from Human Pluripotent Stem Cells","volume":"8","author":"Hannan","year":"2013","journal-title":"Nat. Protoc."},{"key":"ref_218","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/hep.24790","article-title":"Rapid Generation of Mature Hepatocyte-like Cells from Human Induced Pluripotent Stem Cells by an Efficient Three-Step Protocol","volume":"55","author":"Chen","year":"2012","journal-title":"Hepatology"},{"key":"ref_219","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/hep.23354","article-title":"Highly Efficient Generation of Human Hepatocyte-like Cells from Induced Pluripotent Stem Cells","volume":"51","author":"Noto","year":"2010","journal-title":"Hepatology"},{"key":"ref_220","first-page":"545","article-title":"CRISPR-Mediated Genomic Addition to CPS1 Deficient iPSCs Is Insufficient to Restore Nitrogen Homeostasis","volume":"94","author":"Nitzahn","year":"2021","journal-title":"Yale J. Biol. Med."},{"key":"ref_221","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.jhep.2014.10.016","article-title":"Phenotypic and Functional Analyses Show Stem Cell-Derived Hepatocyte-like Cells Better Mimic Fetal Rather than Adult Hepatocytes","volume":"62","author":"Baxter","year":"2015","journal-title":"J. Hepatol."},{"key":"ref_222","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.scr.2012.06.004","article-title":"Hepatocyte-like Cells Differentiated from Human Induced Pluripotent Stem Cells: Relevance to Cellular Therapies","volume":"9","author":"Yu","year":"2012","journal-title":"Stem Cell Res."},{"key":"ref_223","doi-asserted-by":"crossref","unstructured":"Wang, X., Rao, J., Tan, Z., Xun, T., Zhao, J., and Yang, X. (2022). Inflammatory Signaling on Cytochrome P450-Mediated Drug Metabolism in Hepatocytes. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1043836"},{"key":"ref_224","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.immuni.2019.10.014","article-title":"Type I Interferon Signaling Disrupts the Hepatic Urea Cycle and Alters Systemic Metabolism to Suppress T Cell Function","volume":"51","author":"Lercher","year":"2019","journal-title":"Immunity"},{"key":"ref_225","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1124\/dmd.112.046276","article-title":"Isoform-Specific Regulation of Cytochromes P450 Expression by Estradiol and Progesterone","volume":"41","author":"Choi","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"ref_226","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1007\/s12015-024-10776-6","article-title":"Progesterone Receptor Is Constitutively Expressed in Induced Pluripotent Stem Cells (iPSCs)","volume":"20","author":"Manganelli","year":"2024","journal-title":"Stem Cell Rev. Rep."},{"key":"ref_227","doi-asserted-by":"crossref","first-page":"12538","DOI":"10.1073\/pnas.1209979109","article-title":"Donor-Dependent Variations in Hepatic Differentiation from Human-Induced Pluripotent Stem Cells","volume":"109","author":"Kajiwara","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_228","doi-asserted-by":"crossref","first-page":"100440","DOI":"10.1016\/j.crmeth.2023.100440","article-title":"Quantitative Chemometric Phenotyping of Three-Dimensional Liver Organoids by Raman Spectral Imaging","volume":"3","author":"LaLone","year":"2023","journal-title":"Cell Rep. Methods"},{"key":"ref_229","doi-asserted-by":"crossref","first-page":"4631","DOI":"10.1038\/s41467-023-40298-7","article-title":"Development of Plasmodium Falciparum Liver-Stages in Hepatocytes Derived from Human Fetal Liver Organoid Cultures","volume":"14","author":"Yang","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_230","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1039\/D4LC00149D","article-title":"Reproducible Generation of Human Liver Organoids (HLOs) on a Pillar Plate Platform via Microarray 3D Bioprinting","volume":"24","author":"Shrestha","year":"2024","journal-title":"Lab A Chip"},{"key":"ref_231","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jss.2018.01.031","article-title":"Hepatocyte Transplantation: Past Efforts, Current Technology, and Future Expansion of Therapeutic Potential","volume":"226","author":"Anderson","year":"2018","journal-title":"J. Surg. Res."},{"key":"ref_232","doi-asserted-by":"crossref","first-page":"963689720964384","DOI":"10.1177\/0963689720964384","article-title":"Investigation of Clinical Safety of Human iPS Cell-Derived Liver Organoid Transplantation to Infantile Patients in Porcine Model","volume":"29","author":"Tsuchida","year":"2020","journal-title":"Cell Transplant."},{"key":"ref_233","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1080\/17460441.2021.1972255","article-title":"How Necessary Are Animal Models for Modern Drug Discovery?","volume":"16","author":"Singh","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_234","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1053\/j.gastro.2016.05.051","article-title":"Comparison of Gene Expression Patterns Between Mouse Models of Nonalcoholic Fatty Liver Disease and Liver Tissues from Patients","volume":"151","author":"Teufel","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_235","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s00204-020-02939-4","article-title":"Cross-Species Analysis of Hepatic Cytochrome P450 and Transport Protein Expression","volume":"95","author":"Hammer","year":"2021","journal-title":"Arch. Toxicol."},{"key":"ref_236","doi-asserted-by":"crossref","unstructured":"Albadry, M., K\u00fcttner, J., Grzegorzewski, J., Dirsch, O., Kindler, E., Klopfleisch, R., Liska, V., Moulisova, V., Nickel, S., and Palek, R. (2024). Cross-Species Variability in Lobular Geometry and Cytochrome P450 Hepatic Zonation: Insights into CYP1A2, CYP2D6, CYP2E1 and CYP3A4. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1404938"},{"key":"ref_237","doi-asserted-by":"crossref","unstructured":"Cunningham, R.P., and Porat-Shliom, N. (2021). Liver Zonation-Revisiting Old Questions with New Technologies. Front. Physiol., 12.","DOI":"10.3389\/fphys.2021.732929"},{"key":"ref_238","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcmgh.2023.05.010","article-title":"In Vivo and In Vitro Models to Study Liver Fibrosis: Mechanisms and Limitations","volume":"16","author":"Lee","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"ref_239","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13287-025-04139-2","article-title":"Advances in Liver Organoids: Replicating Hepatic Complexity for Toxicity Assessment and Disease Modeling","volume":"16","author":"Shao","year":"2025","journal-title":"Stem Cell Res. Ther."},{"key":"ref_240","doi-asserted-by":"crossref","unstructured":"Hartlage, A.S., and Kapoor, A. (2021). Hepatitis C Virus Vaccine Research: Time to Put Up or Shut Up. Viruses, 13.","DOI":"10.3390\/v13081596"},{"key":"ref_241","doi-asserted-by":"crossref","unstructured":"Du, Y., Broering, R., Li, X., Zhang, X., Liu, J., Yang, D., and Lu, M. (2021). In Vivo Mouse Models for Hepatitis B Virus Infection and Their Application. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.766534"},{"key":"ref_242","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.drudis.2015.09.002","article-title":"A Comparison between Genetically Humanized and Chimeric Liver Humanized Mouse Models for Studies in Drug Metabolism and Toxicity","volume":"21","author":"Scheer","year":"2016","journal-title":"Drug Discov. Today"},{"key":"ref_243","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1053\/j.gastro.2011.01.001","article-title":"A Humanized Mouse Model to Study Hepatitis C Virus Infection, Immune Response, and Liver Disease","volume":"140","author":"Washburn","year":"2011","journal-title":"Gastroenterology"},{"key":"ref_244","doi-asserted-by":"crossref","unstructured":"Taymour, R., Chicaiza-Cabezas, N.A., Gelinsky, M., and Lode, A. (2022). Core-Shell Bioprinting of Vascularizedin Vitroliver Sinusoid Models. Biofabrication, 14.","DOI":"10.1088\/1758-5090\/ac9019"},{"key":"ref_245","doi-asserted-by":"crossref","unstructured":"Skardal, A., Devarasetty, M., Kang, H.-W., Seol, Y.-J., Forsythe, S.D., Bishop, C., Shupe, T., Soker, S., and Atala, A. (2016). Bioprinting Cellularized Constructs Using a Tissue-Specific Hydrogel Bioink. J. Vis. Exp., e53606.","DOI":"10.3791\/53606-v"},{"key":"ref_246","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.5966\/sctm.2015-0235","article-title":"Functional Maturation of Induced Pluripotent Stem Cell Hepatocytes in Extracellular Matrix-A Comparative Analysis of Bioartificial Liver Microenvironments","volume":"5","author":"Wang","year":"2016","journal-title":"Stem Cells Transl. Med."},{"key":"ref_247","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s13770-023-00576-3","article-title":"Three Dimensional Bioprinting for Hepatic Tissue Engineering: From In Vitro Models to Clinical Applications","volume":"21","author":"Kasturi","year":"2024","journal-title":"Tissue Eng. Regen. Med."},{"key":"ref_248","doi-asserted-by":"crossref","unstructured":"Deng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., and Zhang, X. (2019). Engineered Liver-on-a-Chip Platform to Mimic Liver Functions and Its Biomedical Applications: A Review. Micromachines, 10.","DOI":"10.3390\/mi10100676"},{"key":"ref_249","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1039\/C8LC00333E","article-title":"Design and Fabrication of a Liver-on-a-Chip Platform for Convenient, High-Efficient, and Safe in Situ Perfusion Culture of 3D Hepatic Spheroids","volume":"18","author":"Ma","year":"2018","journal-title":"Lab A Chip"},{"key":"ref_250","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.bios.2016.07.094","article-title":"Accessing 3D Microtissue Metabolism: Lactate and Oxygen Monitoring in Hepatocyte Spheroids","volume":"87","author":"Weltin","year":"2017","journal-title":"Biosens. Bioelectron."},{"key":"ref_251","doi-asserted-by":"crossref","unstructured":"Ahmed, H.M.M., Salerno, S., Morelli, S., Giorno, L., and De Bartolo, L. (2017). 3D Liver Membrane System by Co-Culturing Human Hepatocytes, Sinusoidal Endothelial and Stellate Cells. Biofabrication, 9.","DOI":"10.1088\/1758-5090\/aa70c7"},{"key":"ref_252","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1039\/C6LC01374K","article-title":"Mimicking Liver Sinusoidal Structures and Functions Using a 3D-Configured Microfluidic Chip","volume":"17","author":"Du","year":"2017","journal-title":"Lab A Chip"},{"key":"ref_253","doi-asserted-by":"crossref","first-page":"17677","DOI":"10.1021\/acs.analchem.2c04530","article-title":"\u201cOrgan-in-a-Column\u201d Coupled On-Line with Liquid Chromatography-Mass Spectrometry","volume":"94","author":"Kogler","year":"2022","journal-title":"Anal. Chem."},{"key":"ref_254","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1007\/s13346-022-01147-0","article-title":"Three-Dimensional (3D) Liver Cell Models\u2014A Tool for Bridging the Gap between Animal Studies and Clinical Trials When Screening Liver Accumulation and Toxicity of Nanobiomaterials","volume":"12","author":"Tutty","year":"2022","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev-bioeng-060418-052305","article-title":"Challenges and Opportunities in the Design of Liver-on-Chip Microdevices","volume":"21","author":"Ehrlich","year":"2019","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"ref_256","doi-asserted-by":"crossref","unstructured":"Chliara, M.A., Elezoglou, S., and Zergioti, I. (2022). Bioprinting on Organ-on-Chip: Development and Applications. Biosensors, 12.","DOI":"10.3390\/bios12121135"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9432\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T10:59:09Z","timestamp":1759229949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/19\/9432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":256,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["ijms26199432"],"URL":"https:\/\/doi.org\/10.3390\/ijms26199432","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2025,9,26]]}}}